This compound is primarily utilized in the development of pharmaceutical agents, particularly as a potential therapeutic for bacterial and fungal infections. Its benzoxaborole structure enables it to interact with microbial enzymes, inhibiting their activity and disrupting pathogen growth. Research has shown promise in its application for treating conditions like onychomycosis and other fungal infections due to its broad-spectrum antifungal properties. Additionally, it is being explored for its anti-inflammatory and immunomodulatory effects, making it a candidate for treating autoimmune diseases. Its hydrochloride form enhances solubility, improving bioavailability for oral or topical administration in drug formulations. Ongoing studies are investigating its efficacy and safety in clinical settings.